Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study

BACKGROUND: The addition of cetuximab (CTX) to perioperative chemotherapy (CT) for operable colorectal liver metastases resulted in a shorter progression-free survival. Details of disease progression are described to further inform the primary study outcome. METHODS: A total of 257 KRAS wild-type pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Pugh, Siân A, Bowers, Megan, Ball, Alexandre, Falk, Stephen, Finch-Jones, Meg, Valle, Juan W, O'Reilly, Derek A, Siriwardena, Ajith K, Hornbuckle, Joanne, Rees, Myrddin, Rees, Charlotte, Iveson, Tim, Hickish, Tamas, Maishman, Tom, Stanton, Louise, Dixon, Elizabeth, Corkhill, Andrea, Radford, Mike, Garden, O James, Cunningham, David, Maughan, Tim S, Bridgewater, John A, Primrose, John N
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4985352/
https://ncbi.nlm.nih.gov/pubmed/27434036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.208
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados